Lilly Issues Earnings April 18, Pfizer April 19
This article was originally published in The Pink Sheet Daily
Executive Summary
Anticipated highlights include implications of favorable patent ruling for Lilly’s Zyprexa and Pfizer’s withdrawal of its COX-2 inhibitor Bextra. Upcoming earnings week also includes Merck, J&J, Amgen, Roche, Schering-Plough, Novartis and Wyeth.